COMMUNIQUÉS West-GlobeNewswire

Olainfarm Group sales increase by 14% in Q1 2019
16/04/2019
Consolidated sales – March and 3 months Preliminary consolidated results of JSC Olainfarm for March 2019, show that the Group has made sales worth 10.8 million euros, which represents an increase by 3% compared to March [...]
C-RAD meddelar att teckningsoptioner har utnyttjats och att tilldelning av aktier skett
16/04/2019
C-RAD AB (publ) ("C-RAD" eller "Bolaget") meddelar att 264 000 teckningsoptioner som emitterades efter beslut av årsstämman den 14 april 2016 har utnyttjats av innehavare till en kurs om 11,80 kronor och att styrelsen [...]
Motif Bio Presents New Iclaprim Data at ECCMID 2019
16/04/2019
NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that new iclaprim data are being [...]
Helix BioPharma Corp. Reports Voting Results
16/04/2019
RICHMOND HILL, Ontario, April 15, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Canada House Wellness Group Welcomes Gaetan Lussier and Shawn Graham to its Board of Directors
16/04/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 15, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) is [...]
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
16/04/2019
U.S. Food and Drug Administration has completed its review and determined that the study may proceed LA JOLLA, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the [...]
NILE Study Results Demonstrating Guardant360’s High Concordance to Tissue Testing in Advanced NSCLC Published in Clinical Cancer Research
15/04/2019
REDWOOD CITY, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that the positive results from the NILE study, a head-to-head comparison of the Guardant360® assay to standard-of- [...]
Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA™ (Omadacycline) with New ECCMID 2019 Data Presentations
15/04/2019
- New microbiology data reinforce activity of NUZYRA against broad range of pathogens commonly associated with community-acquired infections - Study supports no dose adjustments in patients based on BMI AMSTERDAM, The [...]
Proteon Therapeutics Announces Review of Potential Strategic Transactions
15/04/2019
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular [...]
Globus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System
15/04/2019
Continuing the Advancement in Spine Surgery with Expandable Technology Solutions AUDUBON, Pa., April 15, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today [...]
Intellia Therapeutics Announces Three Oral Presentations on In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy
15/04/2019
CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), announced three oral presentations at the 22 nd Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), [...]
Sol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III TWIN Program for the Treatment of Acne Vulgaris
15/04/2019
Patient enrollment of the pivotal Phase III TWIN clinical trials is on schedule Top-line results expected in the fourth quarter of 2019 NESS ZIONA, Israel, April 15, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. ( [...]
LHC Group Announces First Quarter 2019 Earnings Release and Conference Call Dates
15/04/2019
LAFAYETTE, La., April 15, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc . (NASDAQ: LHCG) today announced details for the release of its results for the first quarter ended March 31, 2019. LHC Group plans to issue its first [...]
Assure Holdings Reports Fourth Quarter and Full Year 2018 Financial Results
15/04/2019
2018 Managed Case Volume Increased 79% to 2,799, Expanded into Five States DENVER, April 15, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of [...]
Autolus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
15/04/2019
LONDON, April 15, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the closing of its [...]
Solid Biosciences Announces Upcoming Preclinical Data Presentations at The American Society of Gene and Cell Therapy Annual Meeting
15/04/2019
CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) today announced that preclinical data from its gene therapy program for Duchenne muscular dystrophy (DMD) will be presented at [...]
MSI Methylation Sciences, Inc. (MSI) Update on Recent BC Supreme Court Order for Quark Venture Inc. (Quark) to Pay MSI $20 million USD
15/04/2019
VANCOUVER, B.C., April 15, 2019 (GLOBE NEWSWIRE) -- On March 27 th , 2019, the British Columbia Supreme Court issued a judgement granting MSI leave to enforce its $20M USD Arbitration Award (plus interest and costs) [...]
CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor
15/04/2019
LAS VEGAS, April 15, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products, announced that it has [...]
Amedisys Announces First Quarter Earnings Release and Conference Call Date
15/04/2019
BATON ROUGE, La., April 15, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the first quarter ended March 31, 2019, after the market closes on April 30, 2019. The [...]

Pages